Statistics for Safety and Immunogenicity of H1/IC31H , an Adjuvanted TB Subunit Vaccine, in HIV-Infected Adults with CD4+ Lymphocyte Counts Greater than 350 cells/mm3 : A Phase II, Multi-Centre, Double-Blind, Randomized, Placebo-Controlled Trial
Total visits
views | |
---|---|
Safety and Immunogenicity of H1/IC31H , an Adjuvanted TB Subunit Vaccine, in HIV-Infected Adults with CD4+ Lymphocyte Counts Greater than 350 cells/mm3 : A Phase II, Multi-Centre, Double-Blind, Randomized, Placebo-Controlled Trial | 0 |
Total visits per month
views | |
---|---|
January 2024 | 0 |
February 2024 | 0 |
March 2024 | 0 |
April 2024 | 0 |
May 2024 | 0 |
June 2024 | 0 |
July 2024 | 0 |